The promise of using histone deacetylase inhibitors in combination treatment against breast cancer and other solid tumors
- PMID: 28249539
- DOI: 10.21037/cco.2017.01.05
The promise of using histone deacetylase inhibitors in combination treatment against breast cancer and other solid tumors
Comment on
-
Feedback Activation of Leukemia Inhibitory Factor Receptor Limits Response to Histone Deacetylase Inhibitors in Breast Cancer.Cancer Cell. 2016 Sep 12;30(3):459-473. doi: 10.1016/j.ccell.2016.08.001. Cancer Cell. 2016. PMID: 27622335
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical